Lv1
30 积分 2025-08-19 加入
Developing and Validation of a Multimodal-Based Machine Learning Model for Diagnosis of Usual Interstitial Pneumonia: A Prospective Multicenter Study
1个月前
已完结
Overcoming Resistance to Antibody-Drug Conjugates (ADCs): Mechanisms and Emerging Strategies
1个月前
已完结
TROPION-Lung12: A phase 3 study of adjuvant datopotamab deruxtecan and rilvegostomig in ctDNA-positive or high-risk pathology stage I non–small cell lung cancer
2个月前
已完结
Navigating the landscape of EGFR TKI resistance in EGFR-mutant NSCLC — mechanisms and evolving treatment approaches
2个月前
已完结
Advances in Systemic Therapy for Lung Cancer
2个月前
已关闭
Trastuzumab Rezetecan: First Approval
3个月前
已完结
Trastuzumab Deruxtecan for ERBB2 -Mutant Metastatic Non–Small Cell Lung Cancer With or Without Brain Metastases
3个月前
已完结
Antibody-drug conjugates in the treatment of lung cancer
3个月前
已关闭
Deep learning large-scale drug discovery and repurposing
4个月前
已完结
[The current treatment status and future of antibody drug conjugates in HER-2-alteration non-small cell lung cancer]
7个月前
已完结
皖公网安备34019202002308
